id: tnf_inhibitor_use_to_infection_severity
name: TNF Inhibitor Use â†’ Infection Severity
from_node:
  node_id: tnf_inhibitor_use
  node_name: TNF Inhibitor Use
to_node:
  node_id: infection_severity
  node_name: Infection Severity
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: TNF inhibitors dampen the magnitude of innate immune responses'
- 'Step 2: Altered immune response reduces capacity to control pathogen replication
  and tissue damage'
- 'Step 3: Immunomodulation predisposes to increased severity of infections once acquired'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Ryan Ha et al. 2022. "Increased susceptibility to pneumonia due
    to tumour necrosis factor inhibition and prospective immune system rescue via
    immunotherapy." *Frontiers in Cellular and Infection Microbiology*. https://doi.org/10.3389/fcimb.2022.980868
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.081667'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: host_directed_treatments
  direction: weakens
  strength: moderate
  description: Other immunomodulators and host-directed treatments can mitigate severity
    of TNF inhibitor-associated infections when used alongside antibiotics
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/tnf_inhibitor_use_to_infection_severity.yaml
_category: biological
